Cytodyn Inc (CYDY)

[finesand]

- Mono
-- Pivotal b/c of 525mg results
-- FDA will change protocol
-- Will delay BLA? (Did I get that right?)

NP just cancelled the question? Wow!
So it is as it is: BLA safety depends on some Mono patients and will hence delay the BLA?
FDA changing the Pivotal Mono Trial.

Please correct.

Also:


- Licensing
-- No exclusive license for an indication (outch)
-- because NP thinks CYDY is too strong (???)
(So forget the 50% on sales deal or any other deal?)


Maybe you can inject the big Q about BLA funding!